Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04275375Completed

Autonomic Modulation After Spinal Anesthesia With Depth of Anesthesia and Vital Signs.

Role: lead

NCT03954262Completed

Autonomic Modulation After Propofol Target Controlled Infusion and Bolus Administration

Role: lead

NCT03613961Completed

Effects of Propofol Induction Anaesthesia on the Heart Rate Variability

Role: lead

NCT03072069Completed

Analysis of Autonomic Function During Anesthesia Using Response Surface Model

Role: lead

All 4 trials loaded